Why INR is outside the therapeutic range in patients with acuteischemic stroke and atrial fibrillation

Introduction: Warfarin is still the primary drug used to prevent vascular events in patientswith atrial fibrillation (AF), especially in low-income countries. Therapeutic failure and non-adherenceare common causes of recurrent embolic events. The aim of this study was toinvestigate possible reasons...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Elyar Sadeghi Hokmabadi, Sheida Shaafi, Yalda Sadeghpour, Reza Deljavan, Javad Jalili, Morteza Ghojazadeh, Elyar Alizade Najmi, Saeid Charsouei, Mehdi Farhoudi
Médium: Artigo
Jazyk:Inglês
Vydáno: Tabriz University of Medical Sciences Press 2022-04-01
Edice:Journal of Research in Clinical Medicine
Témata:
cardio-embolic stroke
atrial fibrillation
warfarin
anticoagulants
neurologic manifestation
On-line přístup:https://jrcm.tbzmed.ac.ir/PDF/jrcm-10-6.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky